Canada markets open in 9 hours 3 minutes

Biosenta Inc. (ZRO.CN)

Canadian Sec - Canadian Sec Real Time Price. Currency in CAD
Add to watchlist
0.4900+0.0250 (+5.38%)
At close: 03:21PM EDT
Full screen
Previous Close0.4650
Open0.0000
Bid0.0000 x N/A
Ask0.0000 x N/A
Day's Range0.0000 - 0.0000
52 Week Range
Volume0
Avg. Volume1,901
Market Cap14.513M
Beta (5Y Monthly)0.34
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Newsfile

    Biosenta Inc. Announces Licensing Agreement with Lightweight Concrete Solutions

    Toronto, Ontario and Calgary, Alberta--(Newsfile Corp. - May 8, 2024) - Biosenta Inc. (CSE: ZRO) ("Biosenta" or the "Company") is pleased to announce a strategic milestone, having entered into a license agreement (the "License Agreement") with 2581776 Ontario Inc. (dba Lightweight Concrete Solutions) ("Lightweight Concrete Solutions") pursuant to which Biosenta granted to Lightweight Concrete Solutions a license to use Biosenta's Tri-Filler® technology in connection with certain specialty concre

  • Newsfile

    Biosenta Closes Private Placement Financing

    Toronto, Ontario--(Newsfile Corp. - April 26, 2024) - Biosenta Inc. (CSE: ZRO) (the "Company" or "Biosenta"), is pleased to announce that it has closed its private placement for gross proceeds of $600,000 (the "Offering"), as previously announced on April 19, 2024. Biosenta issued 1,500,000 units (each, a "Unit") under the Offering at a price of $0.40 per Unit, with each Unit consisting of one common share in the capital of the Company (each, a ...

  • Newsfile

    Biosenta Announces Private Placement Financing

    Toronto, Ontario--(Newsfile Corp. - April 19, 2024) - Biosenta Inc. (CSE: ZRO) ("Biosenta" or the "Company") is pleased to announce a non-brokered private placement financing (the "Offering") of up 1,500,000 units of the Company (the "Units") at a price of $0.40 per Unit, for aggregate gross proceeds of up to $600,000.Each Unit will consist of one common share in the capital of the Company and one half of one common share purchase warrant (each ...